Evidence map›Paper›PMID 32388818›Full record

ReviewArchives of toxicology2020

Arsenic intoxication: general aspects and chelating agents.

Geir Bjørklund, Petro Oliinyk, Roman Lysiuk, Md Shiblur Rahaman, Halyna Antonyak, Iryna Lozynska, Larysa Lenchyk, Massimiliano Peana

Open access · bronzeAbstract readReview
In one paragraph

Review in Archives of toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 145 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Arsenome, Arsenobolome, and Arsenobiolome.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Effect of Gentianella acuta (Michx.) Hulten against the arsenic-induced development hindrance of mouse oocytes.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Geir BjørklundCouncil for Nutritional and Environmental Medicine (CONEM), Toften 24, 8610, Mo i Rana, Norway. bjorklund@conem.org.
Petro OliinykDanylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Roman LysiukDanylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Md Shiblur RahamanGraduate School of Environmental Science, Hokkaido University, Sapporo, Japan.
Halyna AntonyakIvan Franko National University of Lviv, Lviv, Ukraine.
Iryna LozynskaDanylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Larysa LenchykNational University of Pharmacy, Kharkiv, Ukraine.
Massimiliano PeanaDepartment of Chemistry and Pharmacy, University of Sassari, Via Vienna 2, 07100, Sassari, Italy. peana@uniss.it.
Danylo Halytsky Lviv National Medical University · UAHokkaido University · JPLviv University · UANational University of Pharmacy · UAThe Research Council of Norway · NOUniversity of Sassari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arsenic (As) is widely used in the modern industry, especially in the production of pesticides, herbicides, wood preservatives, and semiconductors. The sources of As such as contaminated water, air, soil, but also food, can cause serious human diseases. The complex mechanism of As toxicity in the human body is associated with the generation of free radicals and the induction of oxidative damage in the cell. One effective strategy in reducing the toxic effects of As is the usage of chelating agents, which provide the formation of inert chelator-metal complexes with their further excretion from the body. This review discusses different aspects of the use of metal chelators, alone or in combination, in the treatment of As poisoning. Consideration is given to the therapeutic effect of thiol chelators such as meso-2,3-dimercaptosuccinic acid, sodium 2,3-dimercapto-1-propanesulfonate, 2,3-dimercaptopropanol, penicillamine, ethylenediaminetetraacetic acid, and other recent agents against As toxicity. The review also considers the possible role of flavonoids, trace elements, and herbal drugs as promising natural chelating and detoxifying agents.

Indexed as

AnimalsAntidotesArsenicalsArsenic PoisoningChelating AgentsEnvironmental ExposureEnvironmental PollutantsHumansPlant PreparationsRisk AssessmentTreatment OutcomeAntidotesArsenicalsChelating AgentsEnvironmental PollutantsPlant PreparationsAntioxidantsArsenicChelation therapyFlavonoidsHerbal drugsNephroprotectionPoisoningThiol chelators

Identifiers

PMID32388818
PMCPMC7210463
OpenAlexW3023176774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.